Format

Send to

Choose Destination
Nat Med. 2019 Jun;25(6):870-871. doi: 10.1038/s41591-019-0477-4.

In support of mitochondrial replacement therapy.

Author information

1
Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
2
Department of Population Health, New York University School of Medicine, New York, NY, USA.
3
Gould School of Law, University of Southern California, Los Angeles, California, USA.
4
Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, CT, USA.
5
Center for Biomedical Ethics, Stanford University, Palo Alto, CA, USA.
6
Center for Biomedical Ethics and Society, Vanderbilt University, Nashville, TN, USA.
7
Law School, Harvard University, Cambridge, MA, USA.
8
School for the Future of Innovation in Society, Arizona State University, Tempe, AZ, USA. bcd@asu.edu.
9
Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
10
Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
11
School of Law, Georgetown University, Washington DC, USA.
12
Law School, Stanford University, Palo Alto, CA, USA.
13
The Hastings Center, Garrison, NY, USA.
14
Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
15
School of Public Health, University of Alberta, Edmonton, Alberta, Canada. loripknowles@gmail.com.
16
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
17
Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, USA.
18
Carey School of Law, University of Maryland, Baltimore, MD, USA.
19
Medical School, Harvard University, Boston, MA, USA.
20
Kennedy Institute of Ethics, Georgetown University, Washington, DC, USA.
PMID:
31160819
DOI:
10.1038/s41591-019-0477-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center